Page last updated: 2024-10-22

alfuzosin and Electrocardiogram QT Prolonged

alfuzosin has been researched along with Electrocardiogram QT Prolonged in 3 studies

alfuzosin: structure given in first source

Research Excerpts

ExcerptRelevanceReference
" Incidents of adverse cardiac drug reactions are more common in patients with preexisting heart disease than the general population."1.39Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity. ( Bers, DM; Diecke, S; Gong, T; Knowles, JW; Lan, F; Lee, AS; Liang, P; Nguyen, PK; Robbins, RC; Sallam, K; Sanchez-Freire, V; Wang, PJ; Wang, Y; Wu, JC, 2013)
"Alfuzosin is a rare example of a non-antiarrhythmic drug that delays cardiac repolarization not by blocking hK(v)11."1.35Alfuzosin delays cardiac repolarization by a novel mechanism. ( Brown, AM; Chen, Y; Danthi, SJ; Eng, H; Kramer, JW; Kuryshev, YA; Lacerda, AE; Renganathan, M; Yang, T, 2008)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liang, P1
Lan, F1
Lee, AS1
Gong, T1
Sanchez-Freire, V1
Wang, Y1
Diecke, S1
Sallam, K1
Knowles, JW1
Wang, PJ1
Nguyen, PK1
Bers, DM1
Robbins, RC1
Wu, JC1
Extramiana, F1
Maison-Blanche, P1
Cabanis, MJ1
Ortemann-Renon, C1
Beaufils, P1
Leenhardt, A1
Lacerda, AE1
Kuryshev, YA1
Chen, Y1
Renganathan, M1
Eng, H1
Danthi, SJ1
Kramer, JW1
Yang, T1
Brown, AM1

Trials

1 trial available for alfuzosin and Electrocardiogram QT Prolonged

ArticleYear
Clinical assessment of drug-induced QT prolongation in association with heart rate changes.
    Clinical pharmacology and therapeutics, 2005, Volume: 77, Issue:4

    Topics: Adrenergic alpha-Antagonists; Adult; Aza Compounds; Cross-Over Studies; Double-Blind Method; Electro

2005

Other Studies

2 other studies available for alfuzosin and Electrocardiogram QT Prolonged

ArticleYear
Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity.
    Circulation, 2013, Apr-23, Volume: 127, Issue:16

    Topics: Action Potentials; Cardiomyopathy, Dilated; Cardiomyopathy, Hypertrophic, Familial; Cell Differentia

2013
Alfuzosin delays cardiac repolarization by a novel mechanism.
    The Journal of pharmacology and experimental therapeutics, 2008, Volume: 324, Issue:2

    Topics: Action Potentials; Animals; Cell Line; Female; Guinea Pigs; Humans; Long QT Syndrome; Male; Myocytes

2008